PTEN and liver disorder: We demonstrated that Pten null model is a relevant model for studying fibrosis development because (1) liver disease progresses similarly in humans and Pten null mice, (2) the Pten null mice develop progressive and severe fibrosis from 6 months on, and (3) HSCs implicated in fibrosis development in humans are also activated in Pten null mice.